MTOR and neoplasm: AKT1 is a core member of the PI3K/AKT/mTOR signaling pathway and exhibits overactivation or mutations (especially the E17K mutation) in various cancers, promoting tumor development through multiple mechanisms, including inhibition of apoptosis, enhancement of cell proliferation, regulation of cellular metabolism, and angiogenesis.